1[1]Simonet WS,Lacey DL,Dunstan CR et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309-319.
2[2]Harry JG.Total hip replacement and other orthopendic hip procedures[J].Radiol Clin North Am,1995,33:267-287.
3[4]Rodan GA,Martin TJ.Role of osteoblasts in hormoral control of bone resorption-a hypothesis[J].Calcif Tissue Int,1982,34(3):311-318.
4[5]Lacey DL,Timms E,Tan HL et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[J].Cell,1998,93(2):165-176.
5[6]Nakagawa N,Kinosaki M,Yamaguchi K et al.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis[J].Biochem Biophys Res Com Mun,1998,253(2):395-400.
6[7]Crotti TN,Loric M,Dalidjan M et al.Expression of RANK,RANKL and OPG is associated with rheumatoid arthritic,periodontal and periprosthetic tissue[J].Bone,2000,27(Suppl):1-54.
7[8]Itonaga I,Sabokbar A,Murray DW et al.Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages[J].Ann Rheum Dis,2000,59(1):26-31 .
8[9]Kim KJ,Itoh T,Takagi M et al.Mouse osteoclast formation induced by joint fluids from failed total hip arthoplasty is inhibited by OPG[J].Trans Orthop Res Soc,2000,37(1):218.
9[10]Bekker PJ,Holloway D,Nakanishi A et al.Osteoprotegerin(OPG) has potent and sustained antiresorption activity in postmenopausal women[J].J Bone Miner Res,1999,14(Suppl1):S180.
10Simonet WS, Lacey DL, Dumstan CR, et al. Osteoprotegerina : a noval secreted protein involved in the regulation of bone density. Cell, 1997, 89: 309- 19.
